Our news

1655 news items

Research

Tolerance of efgartimod in myasthenia gravis

On 25/06/2025

Chinese researchers have studied the adverse reactions observed when efgartigimod, a new-generation immunosuppressant used, among other indications, in refractory autoimmune myasthenia, is administered: their work…